Clinical Research Directory
Browse clinical research sites, groups, and studies.
ICOPE INTENSE-K Pilot Study
Sponsor: University Hospital, Toulouse
Summary
ICOPE could constitute the reference model of care for healthy aging. More specifically, our hypothesis is that the intervention implemented in ICOPE may directly or indirectly prevent immuno-senescence, the loss of mobility and the cognitive decline. In future Geroscience clinical trials, ICOPE-Intense could become a benchmark to reduce the rate of aging with a strong non-pharmacological intervention and state a reference intervention to compare with new gerotherapeutic drugs.
Official title: A ICOPE Intense Program Combined With Ketone Ester Pilot Study
Key Details
Gender
All
Age Range
65 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2025-07-09
Completion Date
2025-12-31
Last Updated
2025-07-23
Healthy Volunteers
Yes
Conditions
Interventions
ICOPE intense intervention
The ICOPE-intense intervention (45 hours centre-based (in-group and in-person) multidomain intervention, everyday home-based lifestyle improvement, and weekly individual phone/video call for support)
Ketone Ester (KE) supplementation
12.5g once a day of KE for week 1, and 25g once a day of KE supplementation week 2 to week 8.
Placebo
2.5 g of nonketogenic canola oil
Vitamin D3
2 sprays (i.e. 2000 iu) per day in the morning for 60 days
OMega 3
1000 mg: 1 table per day in the morning during 60 days
vitamin B9
5 mg cp: 1 tablet morning and 1 tablet evening for 60 days
Vitamin B12
250 microgram: 1 tablet per day in the morning for 30 days, then 1 tablet every 10 days for 30 days
Leucin-rich whey
In case of Sarcopenia or low protein intake (\<1.2 g/kg/day), Oral Nutritional Supplementation enriched in essential amino acid (leucin)
ICOPE Step 1
usual ICOPE Step 1
Locations (1)
Cité de la santé - Hopital La Grave
Toulouse, France